Naota Taura

2.0k total citations
87 papers, 1.6k citations indexed

About

Naota Taura is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Naota Taura has authored 87 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 51 papers in Hepatology and 18 papers in Surgery. Recurrent topics in Naota Taura's work include Liver Disease Diagnosis and Treatment (46 papers), Hepatitis C virus research (27 papers) and Liver Disease and Transplantation (15 papers). Naota Taura is often cited by papers focused on Liver Disease Diagnosis and Treatment (46 papers), Hepatitis C virus research (27 papers) and Liver Disease and Transplantation (15 papers). Naota Taura collaborates with scholars based in Japan, Italy and United States. Naota Taura's co-authors include Kazuhiko Nakao, Tatsuki Ichikawa, Hisamitsu Miyaaki, Hidetaka Shibata, Satoshi Miuma, Keisuke Hamasaki, Takuya Honda, Yasuhide Motoyoshi, Katsumi Eguchi and Fuminao Takeshima and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Naota Taura

84 papers receiving 1.6k citations

Peers

Naota Taura
Won Sohn South Korea
Steven Masson United Kingdom
Emer Fitzpatrick United Kingdom
Kwon Yoo South Korea
Yijun Yang United States
Won Sohn South Korea
Naota Taura
Citations per year, relative to Naota Taura Naota Taura (= 1×) peers Won Sohn

Countries citing papers authored by Naota Taura

Since Specialization
Citations

This map shows the geographic impact of Naota Taura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naota Taura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naota Taura more than expected).

Fields of papers citing papers by Naota Taura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naota Taura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naota Taura. The network helps show where Naota Taura may publish in the future.

Co-authorship network of co-authors of Naota Taura

This figure shows the co-authorship network connecting the top 25 collaborators of Naota Taura. A scholar is included among the top collaborators of Naota Taura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naota Taura. Naota Taura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miuma, Satoshi, Hisamitsu Miyaaki, Naota Taura, et al.. (2024). Elevated intestinal fatty acid-binding protein levels as a marker of portal hypertension and gastroesophageal varices in cirrhosis. Scientific Reports. 14(1). 25003–25003.
2.
Matsumoto, Takehiro, et al.. (2020). The Impact of the Health Information Exchange System for the hospital management in Japan. Acta medica Nagasakiensia. 64(2). 39–44. 1 indexed citations
3.
Matsumoto, Takehiro, et al.. (2019). The Impact for Medical Management of the Health Information Exchange Through Changes of the Number of the First Visit Patients and Admission Patients in Japan. Studies in health technology and informatics. 264. 1726–1727. 1 indexed citations
4.
Sasaki, Ryu, Naota Taura, Takuya Honda, et al.. (2018). Ketone bodies as a predictor of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization. Nutrition. 50. 97–103. 6 indexed citations
5.
Miyaaki, Hisamitsu, Takuya Honda, Hidetaka Shibata, et al.. (2017). Significance of psoas muscle thickness as an indicator of muscle atrophy in patients with hepatocellular carcinoma treated with sorafenib. Molecular and Clinical Oncology. 7(3). 449–453. 25 indexed citations
6.
Miuma, Satoshi, Tatsuki Ichikawa, Hisamitsu Miyaaki, et al.. (2016). Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver Transplantation. Journal of Interferon & Cytokine Research. 36(6). 358–366. 4 indexed citations
7.
Miyaaki, Hisamitsu, Tatsuki Ichikawa, Hidetaka Shibata, et al.. (2016). Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis. Hepatology International. 11(1). 125–131. 12 indexed citations
8.
Takeshima, Fuminao, Tatsuki Ichikawa, Toshihisa Matsuzaki, et al.. (2016). Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 62(3). 761–767. 16 indexed citations
9.
Miyaaki, Hisamitsu, Yutaka Nakamura, Tatsuki Ichikawa, et al.. (2015). Predictive value of the efficacy of tolvaptan in liver cirrhosis patients using free water clearance. Biomedical Reports. 3(6). 884–886. 6 indexed citations
10.
Akazawa, Yuko, Hajime Isomoto, Kayoko Matsushima, et al.. (2013). Endoplasmic Reticulum Stress Contributes to Helicobacter Pylori VacA-Induced Apoptosis. PLoS ONE. 8(12). e82322–e82322. 65 indexed citations
11.
Ichikawa, Tatsuki, Naota Taura, Hisamitsu Miyaaki, et al.. (2012). Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantation. Transplant International. 25(4). 433–438. 6 indexed citations
12.
Matsuzaki, Toshihisa, Tatsuki Ichikawa, Hideaki Kondo, et al.. (2012). Prevalence of restless legs syndrome in Japanese patients with chronic liver disease. Hepatology Research. 42(12). 1221–1226. 21 indexed citations
13.
Miyaaki, Hisamitsu, et al.. (2011). 1332 SUPPRESSOR OF CYTOKINE SIGNAL 3 AND IL28 GENETIC VARIATION PREDICT VALUE OF VIRAL RESPONSE TO PEGINTERFERON AND RIBAVIRIN. Journal of Hepatology. 54. S525–S526. 1 indexed citations
14.
Ichikawa, Tatsuki, Naota Taura, Hisamitsu Miyaaki, et al.. (2011). Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells. Journal of Gastroenterology. 47(2). 195–202. 4 indexed citations
15.
Nanashima, Atsushi, Syuuichi Tobinaga, Takafumi Abo, et al.. (2010). Usefulness of sonazoid–ultrasonography during hepatectomy in patients with liver tumors: A preliminary study. Journal of Surgical Oncology. 103(2). 152–157. 21 indexed citations
16.
Nanashima, Atsushi, Syuuichi Tobinaga, Masaki Kunizaki, et al.. (2010). Strategy of treatment for hepatocellular Carcinomas with vascular infiltration in patients undergoing hepatectomy. Journal of Surgical Oncology. 101(7). 557–563. 11 indexed citations
17.
Kusumoto, Koichiro, Hiroshi Yatsuhashi, Mika Fukuda, et al.. (2008). Detection of HBV core promoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B. Journal of Gastroenterology and Hepatology. 23(5). 790–793. 16 indexed citations
18.
Goto, Takashi, Hiroki Ishikawa, Kojiro Matsumoto, et al.. (2008). Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis. International Journal of Oncology. 33(1). 33–40. 17 indexed citations
19.
Nakao, Kazuhiko, Takashi Goto, Daisuke Nishimura, et al.. (2007). Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis. Journal of Hepatology. 47(4). 546–555. 54 indexed citations
20.
Nakamura, Hideki, Hideo Wada, Tomoki Origuchi, et al.. (2006). A case of IgG4‐related autoimmune disease with multiple organ involvement. Scandinavian Journal of Rheumatology. 35(1). 69–71. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026